Regenxbio IncNASDAQ:RGNX
- LAST PRICE11.7000
- TODAY'S CHANGE (%)0.0700 (0.6019%)
- Bid / Lots11.4900/ 1
- Ask / Lots12.3300/ 1
- Open / Previous Close11.6300 / 11.6300
- Day Range
- 52 Week Range
- Volume1,563,503
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RGNX |
|---|---|---|
| 09:32 ET | 7870 | 11.5 |
| 09:34 ET | 323 | 11.485 |
| 09:36 ET | 8015 | 11.6999 |
| 09:38 ET | 700 | 11.66 |
| 09:39 ET | 1327 | 11.63 |
| 09:41 ET | 1100 | 11.57 |
| 09:43 ET | 2576 | 11.565 |
| 09:45 ET | 5463 | 11.6 |
| 09:48 ET | 3935 | 11.62 |
| 09:50 ET | 2520 | 11.66 |
| 09:54 ET | 651 | 11.63 |
| 09:56 ET | 300 | 11.64 |
| 09:57 ET | 1800 | 11.64 |
| 09:59 ET | 500 | 11.64 |
| 10:01 ET | 776 | 11.7 |
| 10:03 ET | 500 | 11.68 |
| 10:06 ET | 300 | 11.7 |
| 10:08 ET | 4298 | 11.685 |
| 10:10 ET | 752 | 11.66 |
| 10:12 ET | 900 | 11.66 |
| 10:14 ET | 1000 | 11.66 |
| 10:15 ET | 100 | 11.68 |
| 10:17 ET | 100 | 11.68 |
| 10:19 ET | 300 | 11.69 |
| 10:21 ET | 600 | 11.68 |
| 10:24 ET | 1100 | 11.73 |
| 10:26 ET | 700 | 11.73 |
| 10:28 ET | 400 | 11.705 |
| 10:30 ET | 1100 | 11.72 |
| 10:32 ET | 613 | 11.715 |
| 10:33 ET | 356 | 11.69 |
| 10:35 ET | 300 | 11.7 |
| 10:37 ET | 2364 | 11.71 |
| 10:42 ET | 200 | 11.745 |
| 10:44 ET | 1600 | 11.74 |
| 10:46 ET | 200 | 11.75 |
| 10:48 ET | 1449 | 11.725 |
| 10:50 ET | 600 | 11.7299 |
| 10:53 ET | 400 | 11.7 |
| 10:55 ET | 200 | 11.69 |
| 10:57 ET | 700 | 11.64 |
| 11:00 ET | 2500 | 11.655 |
| 11:02 ET | 100 | 11.64 |
| 11:04 ET | 100 | 11.64 |
| 11:06 ET | 1900 | 11.64 |
| 11:08 ET | 100 | 11.64 |
| 11:09 ET | 100 | 11.63 |
| 11:11 ET | 3332 | 11.63 |
| 11:13 ET | 3575 | 11.65 |
| 11:15 ET | 307 | 11.67 |
| 11:18 ET | 300 | 11.65 |
| 11:22 ET | 703 | 11.68 |
| 11:24 ET | 1020 | 11.69 |
| 11:26 ET | 250 | 11.68 |
| 11:27 ET | 1100 | 11.67 |
| 11:31 ET | 300 | 11.65 |
| 11:33 ET | 2000 | 11.68 |
| 11:36 ET | 200 | 11.68 |
| 11:38 ET | 716 | 11.675 |
| 11:40 ET | 1532 | 11.665 |
| 11:42 ET | 100 | 11.66 |
| 11:45 ET | 945 | 11.6438 |
| 11:47 ET | 1200 | 11.65 |
| 11:49 ET | 901 | 11.63 |
| 11:51 ET | 3941 | 11.67 |
| 11:54 ET | 600 | 11.71 |
| 11:58 ET | 1200 | 11.71 |
| 12:00 ET | 1200 | 11.73 |
| 12:02 ET | 500 | 11.73 |
| 12:03 ET | 200 | 11.74 |
| 12:05 ET | 100 | 11.735 |
| 12:07 ET | 1134 | 11.719 |
| 12:12 ET | 1000 | 11.715 |
| 12:14 ET | 1592 | 11.74 |
| 12:16 ET | 1943 | 11.775 |
| 12:18 ET | 400 | 11.77 |
| 12:20 ET | 100 | 11.77 |
| 12:23 ET | 500 | 11.78 |
| 12:27 ET | 300 | 11.79 |
| 12:30 ET | 200 | 11.79 |
| 12:32 ET | 100 | 11.79 |
| 12:34 ET | 290 | 11.79 |
| 12:36 ET | 200 | 11.78 |
| 12:38 ET | 500 | 11.79 |
| 12:39 ET | 600 | 11.76 |
| 12:41 ET | 200 | 11.77 |
| 12:48 ET | 1916 | 11.76 |
| 12:52 ET | 637 | 11.77 |
| 12:56 ET | 400 | 11.76 |
| 12:57 ET | 400 | 11.77 |
| 12:59 ET | 100 | 11.78 |
| 01:01 ET | 500 | 11.75 |
| 01:03 ET | 100 | 11.755 |
| 01:06 ET | 3200 | 11.77 |
| 01:08 ET | 1775 | 11.765 |
| 01:10 ET | 300 | 11.755 |
| 01:12 ET | 7101 | 11.75 |
| 01:15 ET | 1799 | 11.79 |
| 01:17 ET | 2140 | 11.79 |
| 01:19 ET | 400 | 11.8 |
| 01:21 ET | 1027 | 11.79 |
| 01:24 ET | 550 | 11.78 |
| 01:26 ET | 400 | 11.77 |
| 01:28 ET | 800 | 11.75 |
| 01:30 ET | 1700 | 11.73 |
| 01:32 ET | 500 | 11.67 |
| 01:33 ET | 904 | 11.6 |
| 01:35 ET | 7982 | 11.56 |
| 01:37 ET | 3016 | 11.58 |
| 01:39 ET | 1584 | 11.65 |
| 01:42 ET | 900 | 11.6599 |
| 01:44 ET | 200 | 11.65 |
| 01:46 ET | 618 | 11.67 |
| 01:48 ET | 100 | 11.67 |
| 01:50 ET | 2804 | 11.72 |
| 01:51 ET | 1400 | 11.72 |
| 01:53 ET | 200 | 11.7 |
| 01:55 ET | 1231 | 11.7 |
| 01:57 ET | 2009 | 11.72 |
| 02:00 ET | 474 | 11.718 |
| 02:02 ET | 1436 | 11.75 |
| 02:04 ET | 400 | 11.77 |
| 02:06 ET | 2079 | 11.78 |
| 02:08 ET | 600 | 11.78 |
| 02:09 ET | 800 | 11.79 |
| 02:11 ET | 200 | 11.8 |
| 02:13 ET | 2578 | 11.8 |
| 02:15 ET | 2100 | 11.8 |
| 02:18 ET | 2000 | 11.8 |
| 02:20 ET | 300 | 11.81 |
| 02:22 ET | 615 | 11.82 |
| 02:24 ET | 5445 | 11.84 |
| 02:26 ET | 1237 | 11.84 |
| 02:27 ET | 1219 | 11.87 |
| 02:29 ET | 3300 | 11.83 |
| 02:31 ET | 100 | 11.84 |
| 02:33 ET | 100 | 11.83 |
| 02:36 ET | 1831 | 11.83 |
| 02:38 ET | 3081 | 11.85 |
| 02:42 ET | 1420 | 11.85 |
| 02:44 ET | 200 | 11.85 |
| 02:45 ET | 3442 | 11.9 |
| 02:47 ET | 5691 | 11.92 |
| 02:51 ET | 3040 | 11.85 |
| 02:54 ET | 3981 | 11.9 |
| 02:56 ET | 200 | 11.9 |
| 03:00 ET | 6442 | 11.95 |
| 03:02 ET | 1900 | 11.94 |
| 03:03 ET | 400 | 11.94 |
| 03:05 ET | 1300 | 11.94 |
| 03:07 ET | 780 | 11.98 |
| 03:09 ET | 1800 | 11.99 |
| 03:12 ET | 209 | 11.97 |
| 03:14 ET | 1100 | 11.95 |
| 03:16 ET | 1500 | 11.96 |
| 03:18 ET | 1224 | 11.97 |
| 03:20 ET | 1447 | 11.98 |
| 03:21 ET | 100 | 11.97 |
| 03:25 ET | 1376 | 11.97 |
| 03:27 ET | 1187 | 12 |
| 03:30 ET | 200 | 12 |
| 03:32 ET | 2613 | 11.98 |
| 03:34 ET | 500 | 11.99 |
| 03:36 ET | 200 | 11.98 |
| 03:38 ET | 8379 | 11.8425 |
| 03:39 ET | 6886 | 11.68 |
| 03:41 ET | 4172 | 11.69 |
| 03:43 ET | 7082 | 11.65 |
| 03:45 ET | 3385 | 11.595 |
| 03:48 ET | 4742 | 11.565 |
| 03:50 ET | 700 | 11.565 |
| 03:52 ET | 15794 | 11.63 |
| 03:54 ET | 3084 | 11.6 |
| 03:56 ET | 30063 | 11.63 |
| 03:57 ET | 31454 | 11.63 |
| 03:59 ET | 21738 | 11.7 |
Jun 24, 2024
REGENXBIO Announces Expansion of AFFINITY DUCHENNE(R) Trial to Include a New Cohort of Younger Patients, from 7:05AM ET on Monday Jun 24, 2024 by Dow Jones
7:05AM ET on Monday Jun 24, 2024 by Dow Jones
Jun 20, 2024
DJ REGENXBIO Price Target Maintained With a $38.00/Share by HC Wainwright & Co., from 11:35AM ET on Thursday Jun 20, 2024 by Dow Jones
11:35AM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 18, 2024
Jun 12, 2024
DJ Regenxbio Shifts CEO to Chairman, COO to Chief Executive, from 7:26AM ET on Wednesday Jun 12, 2024 by Dow Jones
7:26AM ET on Wednesday Jun 12, 2024 by Dow JonesREGENXBIO Announces Leadership Transition, from 7:05AM ET on Wednesday Jun 12, 2024 by Dow Jones
7:05AM ET on Wednesday Jun 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Regenxbio Inc | 566.9M | -2.0x | --- |
Y-mAbs Therapeutics Inc | 527.9M | -24.4x | --- |
SAGE Therapeutics Inc | 652.4M | -1.3x | --- |
Zymeworks Inc | 593.9M | -4.8x | --- |
WAVE Life Sciences Ltd | 535.8M | -9.7x | --- |
Urogen Pharma Ltd | 706.6M | -4.9x | --- |
Company Information
REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address genetic diseases. The Company is focused on its internal development pipeline in three areas: retinal, neuromuscular and neurodegenerative diseases. Its investigational AAV therapeutics include ABBV-RGX-314, RGX-202 and RGX-121. It is developing ABBV-RGX-314 in collaboration with AbbVie to treat large patient populations impacted by wet age-related macular degeneration, diabetic retinopathy (DR) and other chronic retinal diseases characterized by loss of vision. It is developing RGX-202 to treat Duchenne muscular dystrophy (Duchenne). The Company is developing RGX-121 to treat Mucopolysaccharidosis type II (MPS II), a progressive, neurodegenerative lysosomal storage disorder.
Contact Information
- Headquarters
- 9804 Medical Center DriveROCKVILLE, MD, United States 20850
- Phone
- 240-552-8181
- Fax
- 302-655-5049
Executives
- Director
- Allan Fox
- Chairman of the Board
- Kenneth Mills
- Chief Financial Officer, Executive Vice President
- Vittal Vasista
- President, Chief Executive Officer, Director
- Curran Simpson
- Executive Vice President, Chief Scientific Officer
- Olivier Danos
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $566.9M |
|---|---|
Revenue (TTM) | $86.7M |
Shares Outstanding | 49.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-5.88 |
Book Value | $7.08 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 6.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -306.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
